| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 640,620 | 521,434 | 512,867 | 791,046 | | Cost of Revenue | 288,059 | 257,630 | 252,732 | 379,137 | | | Gross Profit | 352,561 | 263,804 | 260,135 | 411,909 | | | Operating Expenses | | Research Development | 192,664 | 200,249 | 207,579 | 234,222 | | Selling General and Administrative | 60,946 | 134,142 | 63,872 | 70,027 | | Non Recurring | 4,956 | 8,336 | 9,689 |
-
| | Others | 26,446 | 30,356 | 48,274 | 34,814 | | | | Total Operating Expenses | 285,012 | 373,083 | 329,414 |
-
| | | | Operating Income or Loss | 67,549 | (109,279) | (69,279) | 72,846 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,793 | (72) | 1,678 | 16,312 | | Earnings Before Interest And Taxes | 69,342 | (109,351) | (67,601) | 89,158 | | Interest Expense | 1,514 | 88 | 2,118 | 3,566 | | Income Before Tax | 67,828 | (109,439) | (69,719) | 85,592 | | Income Tax Expense | 9,335 | 2,018 | (4,709) | 14,646 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 58,493 | (111,457) | (65,010) | 70,946 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 58,493 | (111,457) | (65,010) | 70,946 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $58,493 | ($111,457) | ($65,010) | $70,946 |
|
0.20% Nasdaq 
0.14%
Income Statement
